Initial DNA analysis of one of the 3,000-year-old elongated skulls found in Paracas, Peru, has revealed that they may not have been come from humans but from a completely new species, according to Paracas Museum assistant director Brien Foerster.
Foerster, who also runs his own tour group company in Peru and has authored 11 books on ancient history, told Ancient Origins that a geneticist who tested skull samples has found that they contain mutated DNA that does not match any known genetic DNA information in GenBank, an open-access sequence database of all the known genetic data in the world.
The unidentified geneticist told Foerster: “It had mtDNA (mitochondrial DNA) with mutations unknown in any human, primate, or animal known so far. But a few fragments I was able to sequence from this sample indicate that if these mutations will hold we are dealing with a new human-like creature, very distant from Homo sapiens, Neanderthals and Denisovans.”
“I am not sure it will even fit into the known evolutionary tree,” the geneticist added.
Geneticist won’t come forward, for now
According to Foerster, the geneticist in question, who apparently does contract work for the US government, is willing to go public, but does not want to come forward until the tests prove the theory conclusively.
Peruvian archaeologist Julio Tello discovered the skulls in 1928 in a massive graveyard in Paracas, desert peninsula in the Pisco Province on the south coast of Peru. Over 300 skulls were discovered and are some of the largest elongated skulls to have been found in the world.
Would you be surprised to hear that the human race is slowly becoming dumber, and dumber? Despite our advancements over the last tens or even hundreds of years, some ‘experts’ believe that humans are losing cognitive capabilities and becoming more emotionally unstable. One Stanford University researcher and geneticist, Dr. Gerald Crabtree, believes that our intellectual decline as a race has much to do with adverse genetic mutations. But human intelligence is suffering for other reasons as well.
According to Crabtree, our cognitive and emotional capabilities are fueled and determined by the combined effort of thousands of genes. If a mutation occurred in any of of these genes, which is quite likely, then intelligence or emotional stability can be negatively impacted.
Here is the definition taken from the Human Genome Project, “A genome is the complete collection of an organism’s genetic material. The human genome is composed of about 20,000 to 25,000 genes located on the 23 pairs of chromosomes in a human cell.
A single human chromosome may contain more than 250 million DNA base pairs, and scientists estimate that the entire human genome consists of about 3 billion base pairs.
In the past eighteen months, scientists discovered more than 100 genetic variations that affect older people, such as: type 2 diabetes, asthma, Alzheimer’s disease, osteoporosis, high blood pressure and heart disease.
Genetic science is moving so fast that people now in their 60′s-80′s will see medical innovations that will touch their lives.
Francis Collins, MD, a leader in the Project, was astounded to see the huge amount of information derived from the genome, particularly in regards to older people.
As an example he cited age-related Macular degeneration, an eye disease troubling almost 2 million, visually impaired Americans. “Using new genomic tools we’ve discovered two genes that account for about 60% of the risk- the rest is smoking. But we were surprised. These genes are involved in inflammation, and everybody was thinking macular degeneration was caused by aging in the back of the eye.”
Macular degeneration tests are now being made using anti-inflammatory drugs, a complete change in the way it was formerly viewed.
Many scientists believe that the Human Genome Project has the potential to revolutionize both therapeutic and preventive medicine by providing insights into the basic biochemical processes that underlie many human diseases.
Categories: Uncategorized Tags: bioinformatics, cancer research, cancer sequencing, CGA Platform, Complete Genomics Analysis Platform, Complete Genomics Initial Public Offering, Complete Genomics IPO, DNA, DNA sequencing platform, dna sequencing services, genome biology, genome research, genome sequencing, genome sequencing technology, genome-based research, human dna sequencing, Human Genome, human genome research, human genome sequencing, human genome sequencing science, sequencing technology, whole genome amplification, whole genome sequencing
It was once thought that the human genome would never be completely mapped out because it was much too complex. The human genome project found that, while complex, human genomes are not as complex as some very undistinguished creatures such as the roundworm and fruit fly.
Nevertheless the breakthrough was enormous and caused an incredible stir among scientists and researchers worldwide, opening doors to research about humans that had never before been seen.
At the center of the breakthrough was Complete Genomics, a California research facility that caused the stir when it announced in 2009 that it had sequenced its first human genome. When they had finished it they submitted the data to the National Center for Biotechnology Information and scientists the world over clamored to see it.
Today Complete Genomics is a full-service life-sciences company. The DNA sequencing platform that they developed is used by researchers around the globe to analyze and sequence human genomes using their proprietary and data management software and their informatics.
When a researcher anywhere in the world needs a genome to be sequenced they send it to Complete Genomics for analysis in Mountain View, California. After sequencing the assembled sequences and variant reports are published and sent back to the various researchers who order them.
The proprietary software that Complete Genomics uses is adjusted for the study of human DNA exclusively, and they can provide researchers with genome variation files and also assembled sequences.
Today there are various research papers that have been submitted using the results found at Complete Genomics. For example, their research was responsible for finding which gene was responsible for Miller Syndrome, a rare craniofacial disorder that had struck 1 member of a family of four.
It’s an amazing time to be alive, to be sure, and Complete Genomics is at the forefront of amazing changes that will soon be taking place that only years ago were hard to even imagine. Their technology will ultimately allow researchers to help find and, possibly, cure many diseases that afflict mankind.
Categories: Complete Genomics Tags: bioinformatics, cancer research, cancer sequencing, CGA Platform, Complete Genomics Analysis Platform, Complete Genomics Initial Public Offering, Complete Genomics IPO, DNA sequencing platform, dna sequencing services, genome biology, genome research, genome-based research, human dna sequencing, Human Genome, human genome research, human genome sequencing, human genome sequencing science, sequencing technology, whole genome amplification, whole genome sequencing